Hangzhou Rixin Pharmaceutical Soars Over 3%! Collaborates with GSK on HRS-9821 and 11 Projects, Pledging $5 Billion in Initial Payment
Hangzhou Rixin Pharmaceutical (01276) surged over 3% in the early trading session, with a price increase of 2.99%, currently reported at HK$77.35 and with an aggregate transaction value of HK$254 mill